- Global network
- About us
-
Knowledge hub
Clinical Trial Supply & Logistics
- Clinical Trial Logistics
- Clinical Trial Supply
- Courier Services & Preconditioned Temperature Controlled Packaging
- GxP-Compliant Cold Chain Transport & Storage
- Decentralised Clinical Trials & Direct-to-Patient Logistics
- Labelling of Medicinal Products
- Laboratory Kits Preparation
- Protocol Review & Project Management
Medicines Access & Patient-Oriented Services
Regulatory & Importation Services
17.02.2026
COREX Clinical Trial Supply Event Series
As COREX celebrates its 15th anniversary, CEO Steve Healy heads to Barcelona for Clinical Trial Supply Europe 2026 (24-25 February) to reflect on how the industry has transformed – and where it's heading next.
"Over the past 15 years, clinical supply has evolved from simply moving drugs from A to B into creating adaptive networks that can pivot when trials shift to patient homes, when new regulations emerge overnight, or when a promising therapy needs to reach a single patient in an emergency," said Steve Healy.
The Barcelona conference comes at a pivotal moment for clinical supply. With 60% of trials now incorporating decentralised elements and regulatory frameworks evolving rapidly across markets, traditional supply models are being challenged.
"We consistently see sponsors facing the same challenges – last-minute protocol changes, unexpected regulatory requirements, supply disruptions that threaten patient continuity," Healy noted. "The companies that succeed are those who build flexibility into their supply strategy from day one."
Visit COREX at Booth 11 to explore how pharmaceutical logistics has evolved beyond simple transportation to become a strategic enabler of clinical success.
"Over the past 15 years, clinical supply has evolved from simply moving drugs from A to B into creating adaptive networks that can pivot when trials shift to patient homes, when new regulations emerge overnight, or when a promising therapy needs to reach a single patient in an emergency," said Steve Healy.
The Barcelona conference comes at a pivotal moment for clinical supply. With 60% of trials now incorporating decentralised elements and regulatory frameworks evolving rapidly across markets, traditional supply models are being challenged.
"We consistently see sponsors facing the same challenges – last-minute protocol changes, unexpected regulatory requirements, supply disruptions that threaten patient continuity," Healy noted. "The companies that succeed are those who build flexibility into their supply strategy from day one."
Visit COREX at Booth 11 to explore how pharmaceutical logistics has evolved beyond simple transportation to become a strategic enabler of clinical success.